Top Story

Incoming radiology, urology leaders at University Hospitals, CWRU seek to expand departments

Dr. Pablo Riera Ros and Dr. Firouz Daneshgari will take over radiology and urology, respectively, in July.

Dr. Pablo Riera Ros

Dr. Pablo Riera Ros

CLEVLEAND, Ohio — The incoming chairman of radiology at Case Western Reserve University and University Hospitals Case Medical Center wants an increased emphasis on translational medicine, while the new chairman of urology envisions “one-stop-shopping” for all diseases in his department.

Dr. Pablo Riera Ros and Dr. Firouz Daneshgari will take over radiology and urology, respectively, in July. Ros was the executive vice chairman in the radiology department at Brigham and Women’s Hospital and also chief of the radiology division at the Dana-Farber Cancer Institute in Boston. Daneshgari was chairman of the Department of Urology & Female Pelvic Surgery at Upstate Medical University in Syracuse, N.Y.

Ros said he wants to move university research into clinical medical care. His own research has focused on using magnetic resonance imaging (MRI) and computerized tomography (CT) technology to better treat gastrointestinal diseases including cancer, according to a university press release.

Ros said he will also draw on his experience managing a large department with a team of collaborators to extend the services of University Hospitals to the smaller surrounding communities.

Daneshgari said he intends to establish integrated and interdisciplinary services in female pelvic surgery, minimally invasive surgery, pediatric urology and other areas of need in Northeast Ohio. Daneshgari’s research focus includes female pelvic floor disorders and female incontinence caused by diabetes and has more than $10 million in federal and industry grants.

Daneshgari also said he wants “one-stop shopping” for patients with urinary incontinence, prostate, kidney and bladder cancer, and other urological diseases.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

He said he looks forward to his new position because he believes his dream, vision and passion for delivering a unique patient experience will be realized.


Reblog this post [with Zemanta]